SPECIAL ALERT: Remember, we need your input to make next week’s new Zacks Ultimate Strategy Session episode the best it can be. There are two ways you can participate:
1) Zacks Mailbag: In this regular segment, Kevin Matras answers your questions ranging from current market conditions, general investing wisdom, usage of the Zacks Rank or any resources of Zacks.com and more. Pretty much anything goes .
2) Portfolio Makeover: Sheraz Mian and Kevin Cook review a customer portfolio to give feedback for improvement. No need to send us personal information such as dollar value of holdings. Simply email us with all of the tickers you own.
Just make sure to email your submissions for either one, or both, by Thursday morning, August 1. Email now to [email protected]
The market got the 25 basis-point cut that was widely expected on Wednesday, but the major indices still plunged on the uncertainty of future easing.
The problem really started at Fed Chair Jerome Powell’s press conference, when he said that today’s action was more like a “mid-cycle” policy adjustment.
In other words, further rate cuts are possible but far from guaranteed.
That’s not what the market wanted to hear, sending the major indices sharply lower before paring some of the losses by the closing bell.
The Dow still slumped by 1.23% (or about 333 points) to 26,864.27. The NASDAQ slipped 1.19% (or around 98 points) to 8175.42, while the S&P dipped 1.09% to 2980.38.
With the rate cut being so widely expected, the market wanted more. It would’ve loved to hear that we were at the beginning of an easing cycle. And we know how the market can throw a tantrum when it doesn’t get what it wants.
Even with today’s selloff though, the major indices were up for July. The NASDAQ increased more than 2%, while the S&P gained 1.3% and the Dow advanced 1%.
That’s a second consecutive month of gains for stocks.
Join the Stock Chat, Search your Stock Ticker
In other news, this was Apple’s first session since reporting a positive earnings surprise and encouraging outlook after the close yesterday. Shares of the iPhone maker were up a little more than 2% today despite the lower market.
If you thought that all the drama was done for this week… think again. On Friday, we’re getting the government’s jobs report for July. It blew past expectations in June by adding 224,000, which had people nervous at the time that the Fed wouldn’t cut rates at the July meeting.
Though not a harbinger of what’s coming on Friday, the ADP jobs report today showed 156,000 jobs added in July, which was inline with expectations.
Well, here we go into August. Let’s hope for THREE straight months of gains!
Today’s Portfolio Highlights:
Large-Cap Trader: The portfolio put the rest of its set-aside cash equally into the following three stocks with 5% allocations each:
• Biogen (BIIB) – a leading biopharma company
• CACI International (CACI) – a provider of IT and network solutions for defense
• Logitech Int’l (LOGI) — a maker of innovative peripherals for the digital world
All three of these companies are Zacks Rank #2s (Buys) in highly-ranked industries. They’ve also suffered through pullbacks and have a lot of upside ground to recover. Read John’s specifics on all of these new buys in the complete commentary.
Technology Innovators: You want to know why Brian likes the solar space right now? Take a look at portfolio position Enphase Energy (ENPH), which soared 30% on Wednesday after reporting a strong quarter. The company beat the Zacks Consensus Estimate by more than 38%, while revenues of a little over $134 million topped our expectations by more than 10%. Needless to say, ENPH was easily the top performer of the day among all ZU portfolios.
Surprise Trader: In the past couple of quarters, WillScot (WSC) has beaten the Zacks Consensus Estimate with triple-digit surprises. Now, on the eve of its nex t report , this provider of modular space and portable storage solutions has a positive Earnings ESP of 11.7%. This Zacks Rank #2 (Buy) reports after the bell tomorrow. Dave sees another low bar for its release, so he added WSC on Wednesday with a 12.5% allocation. To make room, the editor sold Skechers (SKX) for a nice 13.2% return in approximately three weeks. See the full write-up for more on today’s moves.
Insider Trader: When Tracey bought railroad components maker Wabtec (WAB) back in late May, the company had been down more than 30% year to date. And then it suffered a panic sell-off stemming from a downgrade. However, the editor remained patient… and today it paid off. The market liked its recen t quarterly report , so the editor felt this was a great time to sell WAB and secure a 21.3% return in two months.
Healthcare Innovators: Short sellers have begun to attack medical instruments company Penumbra (PEN) after a brokerage saw the potential for a big downside. Kevin was holding onto this name on the possibility of some M&A activity. But today’s pullback convinced the editor to just sell PEN and bank a nearly 25% return in about 10 months. He’ll look to get back into the name once it has moved lower.
Recommendations from Zacks’ Private Portfolios:
Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks’ private recommendation services. If you would like to follow our Buy and Sell signals in real time, we’ve made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks’ portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we’ve predicted with an astonishing 80%+ accuracy). Click here to “test drive” Zacks Ultimate for FREE >>
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.